Akadeum Life Sciences is excited to announce its participation Mesa, a globally recognized program held at the iconic Arizona Biltmore. This premier program brings together senior executives and key decision-makers from the cell and gene therapy industry to engage in critical discussions, presentations, and partnering sessions aimed at advancing the next generation of therapeutics.
Spotlight on Akadeum's Cell Therapy Impact:
Brandon H. McNaughton, PhD, CEO of Akadeum Life Sciences, will present the latest advancements in microbubble cell separation technology. Following a highly successful beta and demo period, Akadeum is moving full steam ahead toward the formal launch of the Alerion™ Microbubble Cell Separation System. Dr. McNaughton will also share results from reagent and instrument user testing demonstrating best-in-class cell isolation performance of Akadeum's cutting-edge Cell & Gene Therapy (C>) manufacturing product portfolio,
Engage with Akadeum:
Conference attendees are encouraged to visit the Akadeum table, where the team will be showcasing the Alerion™ system alongside microbubble leukopak technology and BioRise™ consumables. Cell therapy leaders can see firsthand how Akadeum's innovative microbubble technology can enhance every stage of your cell therapy pipeline, offering advantages such as more viable engineered cells, higher yields, reduced cellular impurities, and significantly faster processing times (with full leukopak separation in as little as 45 minutes).
Partnering Room Access:
For those interested in exploring potential collaborations, Akadeum has a partnering room available for one-on-one meetings. This setting is perfect for like-minded organizations seeking to combine their technologies to drive progress in the cell and gene therapy space. We invite you to schedule a meeting with Brandon McNaughton or other members of the Akadeum team to discuss how we can work together to advance therapeutic innovations. Meetings can be scheduled via Meeting on the Mesa's partneringONE® platform.
